Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Rentokil
RTO
|
+$510M |
| 2 |
Apellis Pharmaceuticals
APLS
|
+$205M |
| 3 |
TFI International
TFII
|
+$146M |
| 4 |
Ambev
ABEV
|
+$133M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$132M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.18B |
| 3 |
Mastercard
MA
|
+$3.67B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.38B |
| 5 |
Amazon
AMZN
|
+$3.16B |
Sector Composition
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.68% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Stellar Bancorp
STEL
$1.61B
| $266K | ﹤0.01% |
+9,039
| New | +$266K |
|
2027
Semtech
SMTC
$5.36B
| $265K | ﹤0.01% |
9,251
| – | – |
|
|
NVRO
2028
DELISTED
NEVRO CORP.
NVRO
| $265K | ﹤0.01% |
6,691
| – | – |
|
2029
Avanos Medical
AVNS
$558M
| $264K | ﹤0.01% |
9,736
| – | – |
|
2030
Digital Turbine
APPS
$480M
| $263K | ﹤0.01% |
17,288
-17,290
| -50% | -$263K |
|
2031
Universal Corp
UVV
$1.38B
| $263K | ﹤0.01% |
4,975
| – | – |
|
2032
Semler Scientific
SMLR
$415M
| $262K | ﹤0.01% |
7,935
-621
| -7% | -$20.5K |
|
|
KDNY
2033
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $262K | ﹤0.01% |
+9,988
| New | +$262K |
|
2034
Center Bancorp
CNOB
$1.25B
| $262K | ﹤0.01% |
10,805
-10,911
| -50% | -$264K |
|
2035
National Bank Holdings
NBHC
$1.47B
| $262K | ﹤0.01% |
6,217
+1
| +0% | +$42 |
|
|
UNIT
2036
Uniti Group
UNIT
$1.69B
| $261K | ﹤0.01% |
47,300
-47,308
| -50% | -$261K |
|
|
MODN
2037
DELISTED
MODEL N, INC.
MODN
| $261K | ﹤0.01% |
6,430
| – | – |
|
2038
Harmonic Inc
HLIT
$1.12B
| $260K | ﹤0.01% |
19,885
-19,885
| -50% | -$260K |
|
2039
OceanFirst Financial
OCFC
$1.03B
| $260K | ﹤0.01% |
12,251
-12,251
| -50% | -$260K |
|
2040
Kratos Defense & Security Solutions
KTOS
$11.1B
| $259K | ﹤0.01% |
25,077
-25,077
| -50% | -$259K |
|
|
CIM
2041
Chimera Investment
CIM
$1.17B
| $257K | ﹤0.01% |
15,619
-15,620
| -50% | -$257K |
|
2042
Newmark Group
NMRK
$3.33B
| $257K | ﹤0.01% |
32,224
-32,228
| -50% | -$257K |
|
2043
Openlane
KAR
$3.12B
| $257K | ﹤0.01% |
19,685
-19,689
| -50% | -$257K |
|
2044
MillerKnoll
MLKN
$1.38B
| $257K | ﹤0.01% |
12,218
-12,216
| -50% | -$257K |
|
|
GTY
2045
Getty Realty Corp
GTY
$1.6B
| $256K | ﹤0.01% |
7,574
| – | – |
|
2046
St. Joe Company
JOE
$2.91B
| $256K | ﹤0.01% |
6,608
| – | – |
|
2047
DigitalOcean
DOCN
$3.11B
| $255K | ﹤0.01% |
10,026
-10,026
| -50% | -$255K |
|
2048
Huron Consulting
HURN
$2.36B
| $255K | ﹤0.01% |
3,513
| – | – |
|
2049
Hope Bancorp
HOPE
$1.41B
| $255K | ﹤0.01% |
19,906
-19,910
| -50% | -$255K |
|
|
RVNC
2050
DELISTED
Revance Therapeutics, Inc.
RVNC
| $255K | ﹤0.01% |
13,795
-33,795
| -71% | -$624K |
|